|
|
By Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F, Arrillaga-Romany IC, Goldberg TE, Callicott JH, Apud JA, Weinberger DR, on August 28th, 2010
Related Articles
Modulatory effects of modafinil on neural circuits regulating emotion and cognition.
Neuropsychopharmacology. 2010 Sep;35(10):2101-9
Authors: Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F… . . . → Read More: Modulatory effects of modafinil on neural circuits regulating emotion and cognition.
By Jin X, Semenova S, Yang L, Ardecky R, Sheffler DJ, Dahl R, Conn PJ, Cosford ND, Markou A, on August 28th, 2010
The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats.
Neuropsychopharmacology. 2010 Sep;35(1… . . . → Read More: The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats.
By Bechtholt-Gompf AJ, Walther HV, Adams MA, Carlezon WA, Ongür D, Cohen BM, on August 28th, 2010
Related Articles
Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.
Neuropsychopharmacology. 2010 Sep;35(10):2049-59
Authors: Bechtholt-Gompf AJ, Walther HV, Adams MA, Car… . . . → Read More: Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.
By Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC, Thiel KJ, Neisewander JL, on August 28th, 2010
Related Articles
Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.
Neuropsychopharmacology. 2010 Sep;35(10):2037-48
Authors: Pentkowski NS, Duke FD, Weber SM, Pock… . . . → Read More: Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.
By McCallum J, Kim JH, Richardson R, on August 28th, 2010
Related Articles
Impaired extinction retention in adolescent rats: effects of D-cycloserine.
Neuropsychopharmacology. 2010 Sep;35(10):2134-42
Authors: McCallum J, Kim JH, Richardson R
The developmental trajectory of … . . . → Read More: Impaired extinction retention in adolescent rats: effects of D-cycloserine.
By Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G, on August 28th, 2010
Related Articles
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
Neuropsychopharmacology. 2010 Sep;35(10):2083-100
… . . . → Read More: Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
By Hammond JC, McCullumsmith RE, Funk AJ, Haroutunian V, Meador-Woodruff JH, on August 28th, 2010
Related Articles
Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
Neuropsychopharmacology. 2010 Sep;35(10):2110-9
Authors: Hammond JC, McCullumsmith RE, Fu… . . . → Read More: Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
By Eggan SM, Stoyak SR, Verrico CD, Lewis DA, on August 28th, 2010
Related Articles
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
Neuropsychopharmacology. 2010 Sep;35(10):2060-71
Authors: Eggan SM, Stoyak SR, V… . . . → Read More: Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
By Nasrallah HA, Gopal S, Gassmann-Mayer C, Quiroz JA, Lim P, Eerdekens M, Yuen E, Hough D, on August 28th, 2010
Related Articles
A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.
Neuropsychopharmacology. 2010 Sep;35(10):2072-82
Authors: Nasrallah HA, Gopal S, Gassma… . . . → Read More: A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.
By Barrett JE, on August 28th, 2010
Related Articles
mGluR2-Positive allosteric modulators: Therapeutic potential for treating cocaine abuse?
Neuropsychopharmacology. 2010 Sep;35(10):2007-8
Authors: Barrett JE
PMID: 20711209 [PubMed – in proce… . . . → Read More: mGluR2-Positive allosteric modulators: Therapeutic potential for treating cocaine abuse?
By Sharma RP, Gavin DP, Grayson DR, on August 28th, 2010
Related Articles
CpG methylation in neurons: message, memory, or mask?
Neuropsychopharmacology. 2010 Sep;35(10):2009-20
Authors: Sharma RP, Gavin DP, Grayson DR
The study of CpG methylation of genomic DNA in neurons … . . . → Read More: CpG methylation in neurons: message, memory, or mask?
By Van den Oever MC, Lubbers BR, Goriounova NA, Li KW, Van der Schors RC, Loos M, Riga D, Wiskerke J, Binnekade R, Stegeman M, Schoffelmeer AN, Mansvelder HD, Smit AB, De Vries TJ, Spijker S, on August 28th, 2010
Related Articles
Extracellular matrix plasticity and GABAergic inhibition of prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.
Neuropsychopharmacology. 2010 Sep;35(10):2120-33
Authors: Van den Oever MC… . . . → Read More: Extracellular matrix plasticity and GABAergic inhibition of prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.
By Paolo Botta, on July 15th, 2010
Alcohol Excites Cerebellar Golgi Cells by Inhibiting the Na+/K+ ATPase
Neuropsychopharmacology 35,
1984 (August 2010). doi:10.1038/npp.2010.76
Authors: Paolo Botta, Fabio M Simões de Souza, Thomas Sangr… . . . → Read More: Alcohol Excites Cerebellar Golgi Cells by Inhibiting the Na+/K+ ATPase
By Yan-zhong Guan, on July 15th, 2010
Ethanol Blocks Long-Term Potentiation of GABAergic Synapses in the Ventral Tegmental Area Involving μ-Opioid Receptors
Neuropsychopharmacology 35,
1841 (August 2010). doi:10.1038/npp.2010.51
Authors: Yan-zhong Guan… . . . → Read More: Ethanol Blocks Long-Term Potentiation of GABAergic Synapses in the Ventral Tegmental Area Involving ?-Opioid Receptors
By Esther Aarts, on July 15th, 2010
Striatal Dopamine Mediates the Interface between Motivational and Cognitive Control in Humans: Evidence from Genetic Imaging
Neuropsychopharmacology 35,
1943 (August 2010). doi:10.1038/npp.2010.68
Authors: Esther Aarts,… . . . → Read More: Striatal Dopamine Mediates the Interface between Motivational and Cognitive Control in Humans: Evidence from Genetic Imaging
By Kristen M Haut, on July 15th, 2010
Prefrontal Cortical Changes Following Cognitive Training in Patients with Chronic Schizophrenia: Effects of Practice, Generalization, and Specificity
Neuropsychopharmacology 35,
1850 (August 2010). doi:10.1038/npp.2010.5… . . . → Read More: Prefrontal Cortical Changes Following Cognitive Training in Patients with Chronic Schizophrenia: Effects of Practice, Generalization, and Specificity
By Robert W Greene, on July 15th, 2010
An Anxiolytic Response Exerted by β3-Adrenoreceptor Activation: Correlation with an Enhanced Subset of Gabaergic Synaptic Responses
Neuropsychopharmacology 35,
1839 (August 2010). doi:10.1038/npp.2010.73
Author: Ro… . . . → Read More: An Anxiolytic Response Exerted by ?3-Adrenoreceptor Activation: Correlation with an Enhanced Subset of Gabaergic Synaptic Responses
By Christian Montag, on July 15th, 2010
Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met Polymorphism Impacts Novelty Seeking and Harm Avoidance
Neuropsychopharmacology 35,
1860 (August 2010). doi:10.1038/npp.2010.55
Authors: Christian Montag, Seb… . . . → Read More: Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met Polymorphism Impacts Novelty Seeking and Harm Avoidance
By Marisa Roberto, on July 15th, 2010
The Endocannabinoid System Tonically Regulates Inhibitory Transmission and Depresses the Effect of Ethanol in Central Amygdala
Neuropsychopharmacology 35,
1962 (August 2010). doi:10.1038/npp.2010.70
Authors: Marisa Robe… . . . → Read More: The Endocannabinoid System Tonically Regulates Inhibitory Transmission and Depresses the Effect of Ethanol in Central Amygdala
By Sandra Chanraud, on July 15th, 2010
Dual Tasking and Working Memory in Alcoholism: Relation to Frontocerebellar Circuitry
Neuropsychopharmacology 35,
1868 (August 2010). doi:10.1038/npp.2010.56
Authors: Sandra Chanraud, Anne-Lise Pitel, Torsten Rohlfing, … . . . → Read More: Dual Tasking and Working Memory in Alcoholism: Relation to Frontocerebellar Circuitry
By Kosuke Kajitani, on July 15th, 2010
Nitric Oxide Synthase Mediates the Ability of Darbepoetin Alfa to Improve the Cognitive Performance of STOP Null Mice
Neuropsychopharmacology 35,
2005 (August 2010). doi:10.1038/npp.2010.66
Authors: Kosuke Kajitani, Mic… . . . → Read More: Nitric Oxide Synthase Mediates the Ability of Darbepoetin Alfa to Improve the Cognitive Performance of STOP Null Mice
By Celia JA Morgan, on July 15th, 2010
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Neuropsychopharmacology 35,
1879 (August 2010). doi:10.1038/npp.2010.58
Authors: Celia JA Morgan, Tom… . . . → Read More: Cannabidiol Attenuates the Appetitive Effects of ?9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
By Abigail G Schindler, on July 15th, 2010
Behavioral Stress May Increase the Rewarding Valence of Cocaine-Associated Cues Through a Dynorphin/κ-Opioid Receptor-Mediated Mechanism without Affecting Associative Learning or Memory Retrieval Mechanisms
Neuropsychopharmacol… . . . → Read More: Behavioral Stress May Increase the Rewarding Valence of Cocaine-Associated Cues Through a Dynorphin/?-Opioid Receptor-Mediated Mechanism without Affecting Associative Learning or Memory Retrieval Mechanisms
By Yuval Silberman, on July 15th, 2010
Lateral Paracapsular GABAergic Synapses in the Basolateral Amygdala Contribute to the Anxiolytic Effects of β3 Adrenoceptor Activation
Neuropsychopharmacology 35,
1886 (August 2010). doi:10.1038/npp.2010.59
Authors… . . . → Read More: Lateral Paracapsular GABAergic Synapses in the Basolateral Amygdala Contribute to the Anxiolytic Effects of ?3 Adrenoceptor Activation
By Monica M Marcus, on July 15th, 2010
Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission
Neuropsychopharmacology 35,
1952 (August 2010). doi:10.1038/npp.2010.69
Authors: Mo… . . . → Read More: Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission
By Guofu Shen, on July 15th, 2010
Calcium/Calmodulin-Dependent Protein Kinase II Mediates Hippocampal Glutamatergic Plasticity During Benzodiazepine Withdrawal
Neuropsychopharmacology 35,
1897 (August 2010). doi:10.1038/npp.2010.61
Authors: Guofu Sh… . . . → Read More: Calcium/Calmodulin-Dependent Protein Kinase II Mediates Hippocampal Glutamatergic Plasticity During Benzodiazepine Withdrawal
By Peter J Rogers, on July 15th, 2010
Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption
Neuropsychopharmacology 35,
1973 (August 2010). doi:10.1038/npp.2010.71
Aut… . . . → Read More: Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption
By Scott Grady, on July 15th, 2010
Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment
Neuropsychopharmacology 35,
1910 (August 2010). doi:10.1038/npp.2010.63
Auth… . . . → Read More: Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment
By Jimmi Nielsen, on July 15th, 2010
Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
Neuropsychopharmacology 35,
1997 (August 2010). doi:10.1038/npp.2010.78
Authors: Jimmi Nielsen, Sø… . . . → Read More: Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
By Richard Sherva, on July 15th, 2010
Variation in Nicotinic Acetylcholine Receptor Genes is Associated with Multiple Substance Dependence Phenotypes
Neuropsychopharmacology 35,
1921 (August 2010). doi:10.1038/npp.2010.64
Authors: Richard Sherva, Henry R Kr… . . . → Read More: Variation in Nicotinic Acetylcholine Receptor Genes is Associated with Multiple Substance Dependence Phenotypes
By Benoit Forget, on July 15th, 2010
Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction
Neuropsychopharmacology 35,
2006 (August 2010). doi:10.1038/npp.2010.62
Authors: Benoit Forget, Carrie Wertheim, Paola Mascia, Ab… . . . → Read More: Noradrenergic ?1 Receptors as a Novel Target for the Treatment of Nicotine Addiction
By thirdrev, on June 16th, 2010
By thirdrev, on June 16th, 2010
Audrey Versini, Nicolas Ramoz, Yann Le Strat, Susann Scherag, Stefan Ehrlich, Claudette Boni, Anke Hinney, Johannes Hebebrand, Lucia Romo, Julien-Daniel Guelfi . . . → Read More: Estrogen Receptor 1 Gene (ESR1) is Associated with Restrictive Anorexia Nervosa
By thirdrev, on June 16th, 2010
By thirdrev, on June 16th, 2010
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
Katherine W Falenski, Andrew J Thorpe, Joel E Schlosburg, Benjamin F Cravatt, Rehab A Abdullah, Tricia H Smith, Dana E Selley, Aron H Lichtman and . . . → Read More: FAAH?/? Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After ?9-Tetrahydrocannabinol and Anandamide Administration
By thirdrev, on June 15th, 2010
Abigail Polter, Eléonore Beurel, Sufen Yang, Rakesha Garner, Ling Song, Courtney A Miller, J David Sweatt, Lori McMahon, Alfred A Bartolucci, Xiaohua Li and . . . → Read More: Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances
By thirdrev, on June 15th, 2010
Benoit Forget, Carrie Wertheim, Paola Mascia, Abhiram Pushparaj, Steven R Goldberg and . . . → Read More: Noradrenergic ? 1 Receptors as a Novel Target for the Treatment of Nicotine Addiction
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
Stefano Marenco, Antonina A Savostyanova, Jan Willem van der Veen, Matthew Geramita, Alexa Stern, Alan S Barnett, Bhaskar Kolachana, Eugenia Radulescu, Fengyu Zhang, Joseph H Callicott, Richard E Straub, Jun Shen and . . . → Read More: Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
Pingxing Xie, Henry R Kranzler, James Poling, Murray B Stein, Raymond F Anton, Lindsay A Farrer . . . → Read More: Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder
By thirdrev, on June 15th, 2010
By thirdrev, on June 15th, 2010
Maite Solas, Bárbara Aisa, María C Mugueta, Joaquín Del Río, Rosa M Tordera and . . . → Read More: Interactions Between Age, Stress and Insulin on Cognition: Implications for Alzheimer’s Disease
By thirdrev, on June 15th, 2010
By thirdrev, on June 8th, 2010
Kobayashi T, Washiyama K, Ikeda K.
Atomoxetine and reboxetine are commonly used as selective norepinephrine reuptake inhibitors (NRIs) for the treatment of attention-deficit-hyperactivity disorder and depression, respectively. Furthermore, recent studies have suggested that NRIs may be useful for the treatment of several other psychiatric disorders. However, the molecular mechanisms underlying the various effects of NRIs have not . . . → Read More: Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.
By thirdrev, on June 8th, 2010
Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, Drevets WC, Zarate CA Jr.
Pregenual anterior cingulate cortex (pgACC) hyperactivity differentiates treatment responders from non-responders to various pharmacological antidepressant interventions, including ketamine, an N-methyl-D-aspartate receptor antagonist. Evidence of pgACC hyperactivition during non-emotional working memory tasks in . . . → Read More: Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.
By thirdrev, on June 8th, 2010
Xu J, DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN.
Cocaine dependence is associated with white matter impairments that may compromise cognitive function and hence drug users’ abilities to engage in and benefit from treatment. The main aim of this study was to assess whether white matter integrity correlates with treatment outcome measures in cocaine . . . → Read More: White matter integrity is associated with treatment outcome measures in cocaine dependence.
By thirdrev, on June 8th, 2010
Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, Bernardi G, Bagni C, Centonze D.
Transcriptional silencing of the gene encoding the fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS). FMRP acts as a translational repressor at central synapses, and molecular and synaptic plasticity studies have shown that the absence . . . → Read More: Abnormal mGlu 5 receptor-endocannabinoid coupling in mice lacking FMRP and BC1 RNA.
By thirdrev, on June 8th, 2010
Adinoff B, Devous MD Sr, Williams MJ, Best SE, Harris TS, Minhajuddin A, Zielinski T, Cullum M.
Changes in the brain’s cholinergic receptor systems underlie several neuropsychiatric disorders, including Alzheimer’s disease, schizophrenia, and depression. An emerging preclinical literature also reveals that acetylcoholine may have an important function in addictive processes, including reward, learning, and memory. This study . . . → Read More: Altered neural cholinergic receptor systems in cocaine-addicted subjects.
By thirdrev, on June 8th, 2010
Petrovsky N, Quednow BB, Ettinger U, Schmechtig A, M?ssner R, Collier DA, K?hn KU, Maier W, Wagner M, Kumari V.
Attentional gating deficits, commonly measured by prepulse inhibition (PPI) of the acoustic startle response (ASR), have been established as an endophenotype of schizophrenia. Prepulse inhibition is heritable and has been associated with polymorphisms in serotonin and dopamine . . . → Read More: Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.
By thirdrev, on June 8th, 2010
Escribano L, Sim?n AM, Gimeno E, Cuadrado-Tejedor M, de Maturana RL, Garc?a-Osta A, Ricobaraza A, P?rez-Mediavilla A, R?o JD, Frechilla D.
Clinical studies suggest that agonists at peroxisome proliferator-activated receptor gamma (PPARgamma) may exert beneficial effects in patients with mild-to-moderate Alzheimer’s disease (AD), but the mechanism for the potential therapeutic interest of this class of drugs . . . → Read More: Rosiglitazone rescues memory impairment in Alzheimer’s transgenic mice: mechanisms involving a reduced amyloid and tau pathology.
By thirdrev, on June 8th, 2010
Maayan L, Vakhrusheva J, Correll CU.
Antipsychotic-related weight gain and metabolic effects are a critical outcome for patients requiring these medications. A literature search using MEDLINE, Web of Science, PsycNET, and EMBASE for randomized, open and double-blind, placebo-controlled trials of medications targeting antipsychotic-induced weight gain was performed. Primary outcome measures were change and endpoint values in . . . → Read More: Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.
By thirdrev, on June 8th, 2010
Arad M, Weiner I.
Women with schizophrenia have later onset and better response to antipsychotic drugs (APDs) than men during reproductive years, but the menopausal period is associated with increased symptom severity and reduced treatment response. Estrogen replacement therapy has been suggested as beneficial but clinical data are inconsistent. Latent inhibition (LI), the capacity to ignore irrelevant . . . → Read More: Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
By thirdrev, on June 8th, 2010
Chen CC, Yang CH, Huang CC, Hsu KS.
The mossy fiber synapses onto hippocampal CA3 neurons show unique molecular features and a wide dynamic range of plasticity. Although acute stress has been well recognized to alter bidirectional long-term synaptic plasticity in the hippocampal CA1 region and dentate gyrus, it remains unclear whether the same effect may also . . . → Read More: Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity.
By thirdrev, on June 8th, 2010
Unschuld PG, Ising M, Roeske D, Erhardt A, Specht M, Kloiber S, Uhr M, M?ller-Myhsok B, Holsboer F, Binder EB.
Galanin (GAL) is an estrogen-inducible neuropeptide, highly expressed in brain regions reported to be involved in regulation of mood and anxiety. GAL possibly has a direct modulatory effect on hypothalamic-pituitary-adrenal (HPA)-axis regulation. Recent data from pharmacological and . . . → Read More: Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
By thirdrev, on June 8th, 2010
Ito R, Canseliet M.
Behaviorally sensitizing regimen of amphetamine (AMPH) exposure has diverse effects on learning, memory, and cognition that are likely to be a consequence of long-term neural adaptations occurring in the cortico-limbic-striatal circuitry. In particular, altered dopamine signaling in the nucleus accumbens and medial prefrontal cortex has been implicated to underlie AMPH-induced changes in . . . → Read More: Amphetamine exposure selectively enhances hippocampus-dependent spatial learning and attenuates amygdala-dependent cue learning.
By thirdrev, on June 8th, 2010
Axel AM, Mikkelsen JD, Hansen HH.
Tesofensine is a novel monoamine reuptake inhibitor that inhibits both norepinephrine, 5-HT, and dopamine (DA) reuptake function. Tesofensine is currently in clinical development for the treatment of obesity, however, the pharmacological basis for its strong effect in obesity management is not clarified. Using a rat model of diet-induced obesity (DIO), we . . . → Read More: Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.
By thirdrev, on June 8th, 2010
Lauro C, Cipriani R, Catalano M, Trettel F, Chece G, Brusadin V, Antonilli L, van Rooijen N, Eusebi F, Fredholm BB, Limatola C.
Fractalkine-CX3CL1 is a neuron-associated chemokine, which modulates microglia-induced neurotoxicity activating the specific and unique receptor CX3CR1. CX3CL1-CX3CR1 interaction modulates the release of cytokines from microglia, reducing the level of tumor necrosis factor-alpha, interleukin-1-beta, and . . . → Read More: Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.
By thirdrev, on June 8th, 2010
Chen GG, Fiori LM, Moquin L, Gratton A, Mamer O, Mechawar N, Turecki G.
Recent studies have implicated alterations in the expression of polyamine-related genes in the brains of suicide completers including widespread downregulation of spermidine-spermine N1-acetyltransferase, the key enzyme in polyamine catabolism, suggesting compensatory mechanisms attempting to increase brain levels of polyamines. Given the complexity . . . → Read More: Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.
By thirdrev, on June 8th, 2010
Nothdurfter C, Tanasic S, Di Benedetto B, Rammes G, Wagner EM, Kirmeier T, Ganal V, Kessler JS, Rein T, Holsboer F, Rupprecht R.
Because of the biochemical colocalization of the 5-HT(3) receptor and antidepressants within raft-like domains and their antagonistic effects at this ligand-gated ion channel, we investigated the impact of lipid raft integrity for . . . → Read More: Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants.
By thirdrev, on June 8th, 2010
Simms JA, Bito-Onon JJ, Chatterjee S, Bartlett SE.
A major obstacle in the development of new medications for the treatment of alcohol use disorders (AUDs) has been the lack of preclinical, oral ethanol consumption paradigms that elicit high consumption. We have previously shown that rats exposed to 20% ethanol intermittently in a two-bottle choice paradigm will consume . . . → Read More: Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading.
By thirdrev, on June 8th, 2010
Ghiglieri V, Sgobio C, Patassini S, Bagetta V, Fejtova A, Giamp? C, Marinucci S, Heyden A, Gundelfinger ED, Fusco FR, Calabresi P, Picconi B.
In mice lacking the central domain of the presynaptic scaffold Bassoon the occurrence of repeated cortical seizures induces cell-type-specific plasticity changes resulting in a general enhancement of the feedforward inhibition within the . . . → Read More: TrkB-BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.
By thirdrev, on June 8th, 2010
Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA, Gennarelli M.
Major depression is a disease characterized by an inability of neuronal systems to show appropriate adaptive plasticity especially under challenging conditions, such as stress. Conversely, pharmacological intervention may normalize such defects through the modulation of factors that might act in concert for the functional . . . → Read More: The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment.
|
|